Brief: Statera Biopharma Receives Notification Letter From Nasdaq Regarding Form 10-Q Filing
23/05/2022 21:18
May 23 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA RECEIVES NOTIFICATION LETTER FROM NASDAQ
REGARDING FORM 10-Q FILING
* STATERA BIOPHARMA - RECEIVED LETTER FROM NASDAQ ON MAY 18,
INDICATING THAT CO HAD NOT COMPLIED WITH CERTAIN LISTING RULE
FOR CONTINUED LISTING
Source text for Eikon: ID:nGNX2GL8Ts
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc